| Lastest Insider Transactions Of GENELUX Corp ( GNLX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| GNLX | GENELUX Corp | Tyree James L | Directior | 2024-12-30 | Sell | 3,460 | 2.46 | 8,512 | 2024-12-30 19:48:31 |
| GNLX | GENELUX Corp | Zindrick Thomas | President and CEO | 2024-12-16 | Sell | 14,315 | 2.34 | 33,497 | 2024-12-18 16:35:13 |
| GNLX | GENELUX Corp | Zak Lourie S. | Chief Financial Officer | 2024-12-16 | Sell | 2,103 | 2.34 | 4,921 | 2024-12-18 16:35:10 |
| GNLX | GENELUX Corp | Smalling Ralph | Head of Regulatory | 2024-12-16 | Sell | 2,510 | 2.34 | 5,873 | 2024-12-18 16:35:09 |
| GNLX | GENELUX Corp | Cappello Joseph | VP, Pharmaceutical Development | 2024-12-16 | Sell | 6,300 | 2.34 | 14,742 | 2024-12-18 16:35:07 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2024-09-12 | Sell | 64,857 | 2.65 | 171,678 | 2024-09-13 18:22:20 |
| GNLX | GENELUX Corp | Tyree James L | Directior | 2024-09-11 | Sell | 1,730 | 2.60 | 4,499 | 2024-09-12 20:40:50 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2024-08-23 | Sell | 91,630 | 2.19 | 200,278 | 2024-08-27 19:23:40 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2024-02-19 | Sell | 6,849 | 2.12 | 14,520 | 2024-07-08 16:30:13 |
| GNLX | GENELUX Corp | Ryder Sean | General Counsel | 2024-02-19 | Sell | 5,496 | 2.12 | 11,652 | 2024-07-08 16:30:11 |
| GNLX | GENELUX Corp | Jewett Caroline | Head of Quality | 2024-02-19 | Sell | 4,961 | 2.12 | 10,517 | 2024-07-08 16:30:09 |
| GNLX | GENELUX Corp | Tyree James L | Directior | 2024-05-29 | Buy | 6,250 | 0.00 | 0 | 2024-06-07 21:45:20 |
| GNLX | GENELUX Corp | Smither John W | Directior | 2024-05-29 | Buy | 6,250 | 0.00 | 0 | 2024-06-07 21:45:18 |
| GNLX | GENELUX Corp | Thomas John | Directior | 2024-05-29 | Buy | 2,500 | 0.00 | 0 | 2024-06-07 21:45:16 |
| GNLX | GENELUX Corp | Mirabelli Mary | Directior | 2024-05-29 | Buy | 8,000 | 0.00 | 0 | 2024-06-07 21:45:08 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2024-05-29 | Buy | 2,500 | 0.00 | 0 | 2024-06-07 21:40:14 |
| GNLX | GENELUX Corp | Zindrick Thomas | President and CEO | 2024-05-29 | Buy | 200,000 | 0.00 | 0 | 2024-06-07 21:40:12 |
| GNLX | GENELUX Corp | Smalling Ralph | Head of Regulatory | 2024-05-29 | Buy | 1,250 | 0.00 | 0 | 2024-06-07 21:40:10 |
| GNLX | GENELUX Corp | Ryder Sean | General Counsel | 2024-05-29 | Buy | 10,000 | 0.00 | 0 | 2024-06-07 21:40:08 |
| GNLX | GENELUX Corp | Zak Lourie S. | Chief Financial Officer | 2024-05-29 | Buy | 31,250 | 0.00 | 0 | 2024-06-07 21:40:05 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2024-05-13 | Sell | 35,966 | 3.62 | 130,377 | 2024-05-15 17:59:42 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2024-05-07 | Sell | 19,944 | 3.78 | 75,300 | 2024-05-09 16:38:35 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2024-04-29 | Sell | 59,999 | 3.23 | 193,934 | 2024-05-01 18:16:57 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2024-04-22 | Sell | 44,395 | 3.51 | 155,647 | 2024-04-24 17:50:04 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2024-04-16 | Sell | 71,420 | 3.59 | 256,227 | 2024-04-18 17:00:55 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-12-15 | Sell | 32,535 | 13.16 | 428,180 | 2023-12-18 16:15:20 |
| GNLX | GENELUX Corp | Tyree James L | Directior | 2023-12-13 | Sell | 9,000 | 13.22 | 118,969 | 2023-12-14 20:59:42 |
| GNLX | GENELUX Corp | Thomas John | Directior | 2023-12-13 | Sell | 9,000 | 13.38 | 120,387 | 2023-12-14 20:58:32 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-12-07 | Sell | 36,800 | 11.85 | 435,995 | 2023-12-08 17:57:37 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-11-21 | Sell | 18,665 | 10.26 | 191,555 | 2023-11-22 16:15:09 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-10-25 | Sell | 5,704 | 19.40 | 110,638 | 2023-10-26 17:07:34 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-10-23 | Sell | 49,987 | 19.97 | 998,365 | 2023-10-25 16:51:48 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-10-24 | Sell | 5,200 | 19.11 | 99,351 | 2023-10-25 16:15:26 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-10-24 | Option Exercise | 5,200 | 6.00 | 31,200 | 2023-10-25 16:15:26 |
| GNLX | GENELUX Corp | Thomas John | Directior | 2023-10-16 | Sell | 3,333 | 20.71 | 69,038 | 2023-10-16 18:39:20 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-10-10 | Sell | 5,200 | 22.01 | 114,462 | 2023-10-11 16:10:07 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-10-10 | Option Exercise | 5,200 | 6.00 | 31,200 | 2023-10-11 16:10:07 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-10-05 | Sell | 14,251 | 24.93 | 355,229 | 2023-10-10 16:49:40 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-10-03 | Sell | 75,690 | 25.49 | 1,929,225 | 2023-10-04 18:43:29 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-09-27 | Sell | 13,546 | 24.41 | 330,669 | 2023-09-29 16:34:47 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-09-25 | Sell | 42,263 | 24.38 | 1,030,181 | 2023-09-27 16:33:32 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-09-26 | Sell | 5,200 | 23.56 | 122,528 | 2023-09-27 16:10:09 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-09-26 | Option Exercise | 5,200 | 6.00 | 31,200 | 2023-09-27 16:10:09 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-09-21 | Sell | 16,591 | 27.85 | 462,001 | 2023-09-25 18:30:43 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-09-20 | Sell | 6,000 | 27.96 | 167,786 | 2023-09-21 16:35:11 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-09-20 | Option Exercise | 6,000 | 6.00 | 36,000 | 2023-09-21 16:35:11 |
| GNLX | GENELUX Corp | Ryder Sean | General Counsel | 2023-09-20 | Sell | 10,000 | 30.00 | 300,000 | 2023-09-21 16:30:38 |
| GNLX | GENELUX Corp | Ryder Sean | General Counsel | 2023-09-20 | Option Exercise | 10,000 | 6.00 | 60,000 | 2023-09-21 16:30:38 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-09-18 | Sell | 62,459 | 24.92 | 1,556,591 | 2023-09-20 16:48:03 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-09-15 | Sell | 10,400 | 21.89 | 227,630 | 2023-09-18 20:13:33 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-09-15 | Option Exercise | 10,400 | 6.00 | 62,400 | 2023-09-18 20:13:33 |
| GNLX | GENELUX Corp | Thomas John | Directior | 2023-09-15 | Sell | 6,667 | 23.45 | 156,313 | 2023-09-18 20:12:03 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-09-13 | Sell | 29,800 | 21.14 | 629,927 | 2023-09-15 20:06:13 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-09-13 | Sell | 44,308 | 21.80 | 965,899 | 2023-09-15 16:19:42 |
| GNLX | GENELUX Corp | Smither John W | Directior | 2023-09-13 | Sell | 900 | 20.78 | 18,702 | 2023-09-14 20:18:41 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-09-11 | Sell | 52,616 | 22.23 | 1,169,868 | 2023-09-13 19:04:45 |
| GNLX | GENELUX Corp | Szalay Aladar | 10% Owner | 2023-09-07 | Sell | 37,277 | 23.57 | 878,600 | 2023-09-11 19:05:01 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-08-30 | Sell | 19,800 | 24.70 | 489,060 | 2023-08-30 19:22:03 |
| GNLX | GENELUX Corp | Jewett Caroline | Head of Quality | 2023-08-18 | Sell | 515 | 23.73 | 12,221 | 2023-08-22 16:18:54 |
| GNLX | GENELUX Corp | Smalling Ralph | Head of Regulatory | 2023-08-18 | Sell | 935 | 23.73 | 22,188 | 2023-08-22 16:18:15 |
| GNLX | GENELUX Corp | Samuelson Doug | Chief Financial Officer | 2023-08-18 | Sell | 1,297 | 23.73 | 30,778 | 2023-08-22 16:17:20 |
| GNLX | GENELUX Corp | Ryder Sean | General Counsel | 2023-08-18 | Sell | 328 | 23.73 | 7,783 | 2023-08-22 16:16:42 |
| GNLX | GENELUX Corp | Cappello Joseph | VP, Pharmaceutical Development | 2023-08-18 | Sell | 3,265 | 23.73 | 77,478 | 2023-08-22 16:15:48 |
| GNLX | GENELUX Corp | Yu Yong | VP, Clinical Trial Operations | 2023-08-18 | Sell | 3,265 | 23.73 | 77,478 | 2023-08-22 16:14:57 |
| GNLX | GENELUX Corp | Zindrick Thomas | President and CEO | 2023-08-18 | Sell | 8,349 | 23.73 | 198,122 | 2023-08-22 16:13:59 |
| GNLX | GENELUX CORP | Zhang Qian | Associate VP, Research | 2023-01-26 | Buy | 200 | 6.25 | 1,250 | 2023-01-31 15:42:00 |
